Annual Interest Expense
$134.00 K
-$1.02 M-88.38%
31 December 2023
Summary:
AcelRx Pharmaceuticals annual interest expense is currently $134.00 thousand, with the most recent change of -$1.02 million (-88.38%) on 31 December 2023. During the last 3 years, it has fallen by -$2.16 million (-94.15%).ACRX Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$0.00
$0.000.00%
31 December 2023
Summary:
AcelRx Pharmaceuticals quarterly interest expense is currently $0.00, unchanged on 31 December 2023.ACRX Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$575.00 K
-$189.00 K-24.74%
31 December 2023
Summary:
AcelRx Pharmaceuticals TTM interest expense is currently $575.00 thousand, with the most recent change of -$189.00 thousand (-24.74%) on 31 December 2023.ACRX TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRX Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -94.2% | -100.0% | -75.1% |
| 5 y5 years | -94.7% | -100.0% | -81.7% |
ACRX Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -99.2% | -100.0% | -97.4% |
AcelRx Pharmaceuticals Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $134.00 K(-88.4%) | $0.00(0.0%) | $575.00 K(-24.7%) |
| Sept 2023 | - | $0.00(-100.0%) | $764.00 K(-24.4%) |
| June 2023 | - | $456.00 K(+283.2%) | $1.01 M(+19.2%) |
| Mar 2023 | - | $119.00 K(-37.0%) | $848.00 K(-24.2%) |
| Dec 2022 | $1.15 M(-49.7%) | $189.00 K(-23.5%) | $1.12 M(-19.9%) |
| Sept 2022 | - | $247.00 K(-15.7%) | $1.40 M(-17.2%) |
| June 2022 | - | $293.00 K(-24.9%) | $1.69 M(-16.6%) |
| Mar 2022 | - | $390.00 K(-16.5%) | $2.02 M(-12.2%) |
| Dec 2021 | $2.29 M(-30.7%) | $467.00 K(-13.2%) | $2.31 M(-11.1%) |
| Sept 2021 | - | $538.00 K(-14.6%) | $2.59 M(-9.9%) |
| June 2021 | - | $630.00 K(-6.3%) | $2.88 M(-7.8%) |
| Mar 2021 | - | $672.00 K(-10.9%) | $3.12 M(-7.4%) |
| Dec 2020 | $3.31 M(+30.4%) | $754.00 K(-8.5%) | $3.37 M(-2.2%) |
| Sept 2020 | - | $824.00 K(-5.5%) | $3.45 M(-0.1%) |
| June 2020 | - | $872.00 K(-5.2%) | $3.45 M(+65.7%) |
| Mar 2020 | - | $920.00 K(+10.7%) | $2.08 M(-33.8%) |
| Dec 2019 | $2.54 M(-79.8%) | $831.00 K(+0.4%) | $3.15 M(-28.4%) |
| Sept 2019 | - | $828.00 K(-266.9%) | $4.39 M(-37.3%) |
| June 2019 | - | -$496.00 K(-125.0%) | $7.00 M(-36.8%) |
| Mar 2019 | - | $1.98 M(-4.5%) | $11.08 M(-11.8%) |
| Dec 2018 | $12.56 M(-10.5%) | $2.08 M(-39.7%) | $12.56 M(-42.7%) |
| Sept 2018 | - | $3.44 M(-3.9%) | $21.92 M(+13.0%) |
| June 2018 | - | $3.58 M(+3.5%) | $19.40 M(+16.0%) |
| Mar 2018 | - | $3.46 M(-69.8%) | $16.72 M(+0.8%) |
| Dec 2017 | $14.04 M(+15.5%) | $11.44 M(+1144.9%) | $16.59 M(+8.9%) |
| Sept 2017 | - | $919.00 K(+1.8%) | $15.24 M(+1.4%) |
| June 2017 | - | $903.00 K(-72.9%) | $15.02 M(+1.5%) |
| Mar 2017 | - | $3.33 M(-67.0%) | $14.80 M(+21.8%) |
| Dec 2016 | $12.15 M | $10.08 M(+1336.3%) | $12.15 M(+134.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2016 | - | $702.00 K(+2.2%) | $5.18 M(-0.2%) |
| June 2016 | - | $687.00 K(+1.0%) | $5.19 M(-1.7%) |
| Mar 2016 | - | $680.00 K(-78.1%) | $5.28 M(-2.3%) |
| Dec 2015 | $5.41 M(+104.8%) | $3.11 M(+336.0%) | $5.41 M(+73.4%) |
| Sept 2015 | - | $713.00 K(-8.2%) | $3.12 M(-3.2%) |
| June 2015 | - | $777.00 K(-3.6%) | $3.22 M(+8.3%) |
| Mar 2015 | - | $806.00 K(-1.8%) | $2.97 M(+12.7%) |
| Dec 2014 | $2.64 M(-84.3%) | $821.00 K(+0.6%) | $2.64 M(-84.8%) |
| Sept 2014 | - | $816.00 K(+54.0%) | $17.37 M(+2.8%) |
| June 2014 | - | $530.00 K(+12.3%) | $16.90 M(+0.8%) |
| Mar 2014 | - | $472.00 K(-97.0%) | $16.78 M(+0.1%) |
| Dec 2013 | $16.76 M(+359.2%) | $15.55 M(+4369.5%) | $16.76 M(+442.4%) |
| Sept 2013 | - | $348.00 K(-13.6%) | $3.09 M(-6.8%) |
| June 2013 | - | $403.00 K(-11.2%) | $3.31 M(-5.6%) |
| Mar 2013 | - | $454.00 K(-75.9%) | $3.51 M(-3.8%) |
| Dec 2012 | $3.65 M(+58.1%) | $1.89 M(+229.0%) | $3.65 M(+67.2%) |
| Sept 2012 | - | $573.00 K(-4.2%) | $2.18 M(+9.9%) |
| June 2012 | - | $598.00 K(+0.7%) | $1.99 M(+28.6%) |
| Mar 2012 | - | $594.00 K(+42.1%) | $1.54 M(-33.1%) |
| Dec 2011 | $2.31 M(+65.3%) | $418.00 K(+10.9%) | $2.31 M(-12.3%) |
| Sept 2011 | - | $377.00 K(+141.7%) | $2.63 M(+7.3%) |
| June 2011 | - | $156.00 K(-88.5%) | $2.45 M(-2.3%) |
| Mar 2011 | - | $1.36 M(+83.4%) | $2.51 M(+79.9%) |
| Dec 2010 | $1.40 M(+12.5%) | $741.00 K(+276.1%) | $1.40 M(+49.8%) |
| Sept 2010 | - | $197.00 K(-7.9%) | $932.00 K(+26.8%) |
| June 2010 | - | $214.00 K(-12.3%) | $735.00 K(+41.1%) |
| Mar 2010 | - | $244.00 K(-11.9%) | $521.00 K(+88.1%) |
| Dec 2009 | $1.24 M(+207.4%) | $277.00 K | $277.00 K |
| Dec 2008 | $404.00 K | - | - |
FAQ
- What is AcelRx Pharmaceuticals annual interest expense?
- What is the all time high annual interest expense for AcelRx Pharmaceuticals?
- What is AcelRx Pharmaceuticals quarterly interest expense?
- What is the all time high quarterly interest expense for AcelRx Pharmaceuticals?
- What is AcelRx Pharmaceuticals TTM interest expense?
- What is the all time high TTM interest expense for AcelRx Pharmaceuticals?
What is AcelRx Pharmaceuticals annual interest expense?
The current annual interest expense of ACRX is $134.00 K
What is the all time high annual interest expense for AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals all-time high annual interest expense is $16.76 M
What is AcelRx Pharmaceuticals quarterly interest expense?
The current quarterly interest expense of ACRX is $0.00
What is the all time high quarterly interest expense for AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals all-time high quarterly interest expense is $15.55 M
What is AcelRx Pharmaceuticals TTM interest expense?
The current TTM interest expense of ACRX is $575.00 K
What is the all time high TTM interest expense for AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals all-time high TTM interest expense is $21.92 M